Institutional members access full text with Ovid®

Share this article on:

The Economic Burden of Acute Coronary Syndromes for Employees and Their Dependents: Medical and Productivity Costs

Page, Robert L. II PharmD, MSPH; Ghushchyan, Vahram PhD; Gifford, Brian PhD; Read, Richard Allen MS; Raut, Monika PhD; Crivera, Concetta PharmD, MPH; Naim, Ahmad B. MD; Damaraju, C.V. PhD; Nair, Kavita V. PhD

Journal of Occupational and Environmental Medicine: July 2013 - Volume 55 - Issue 7 - p 761–767
doi: 10.1097/JOM.0b013e318297323a
Original Articles

Objective: To determine the total burden of illness, including direct and indirect costs for employees and their dependents with acute coronary syndrome (ACS).

Methods: Medical and pharmacy claims along with short-term disability (STD) and long-term disability (LTD) claims from 2007 to 2010 were analyzed using two data sets: Integrated Benefits Institute's Health and Productivity Benchmarking Database (STD and LTD claims) and IMS LifeLink™ Health Plan Data (medical and pharmacy claims).

Results: Employees with ACS lost 60.2 ± 0.29 STD and 397.9 ± 8.09 LTD days per disability incident. For employers, the estimated average per claim productivity loss from STD and LTD was $7943 ± 39.7 and $52,473 ± 1114, respectively. Total annual ACS health care costs per employee were $8170 ± 106, with $7545 ± 104 for annual medical costs. Hospitalizations accounted for 75% of total annual ACS health care costs.

Conclusions: ACS imposes a substantial economic burden on employees, employers, and society.

From the School of Pharmacy (Drs Page, Ghushchyan, and Nair), Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colo; School of Medicine (Dr Page), Department of Physical Medicine, University of Colorado Anschutz Medical Campus, Aurora; Integrated Benefits Institute (Dr Gifford), San Francisco, Calif; Peakstat Statistical Services (Mr Read), Evergreen, Colo; and Janssen Scientific Affairs, LLC, Raritan, NJ (Drs Raut, Crivera, Naim, and Damaraju).

Address correspondence to: Kavita Nair, PhD, School of Pharmacy, University of Colorado, University of Colorado Anschutz Medical Campus, Mail Stop C238, 12580 E Montview Blvd, Aurora, CO 80045 (Kavita.Nair@ucdenver).

Authors Page 2nd, Ghushchyan, Read, Gifford, Raut, Naim, Crivera, Damaraju, and Nair have no relationships/conditions/circumstances that present potential conflict of interest.

The JOEM editorial board and planners have no financial interest related to this research.

Copyright © 2013 by the American College of Occupational and Environmental Medicine